122 related articles for article (PubMed ID: 31190217)
21. Impact of rs12917 MGMT Polymorphism on [
Kewitz-Hempel S; Kurch L; Cepelova M; Volkmer I; Sauerbrey A; Conrad E; Knirsch S; Pöpperl G; Steinbach D; Beer AJ; Kramm CM; Sahlmann CO; Erdlenbruch B; Reinbold WD; Odparlik A; Sabri O; Kluge R; Staege MS
Mol Imaging Biol; 2019 Dec; 21(6):1182-1191. PubMed ID: 30945122
[TBL] [Abstract][Full Text] [Related]
22. Association between Interleukin-1β Gene -511C>T/+3954C>T Polymorphisms and Aggressive Periodontitis Susceptibility: Evidence from a Meta-Analysis.
Hu YY; Liu JH; Jiang GB; Yuan RX; Niu YM; Shen M
Med Sci Monit; 2015 Jun; 21():1617-24. PubMed ID: 26038188
[TBL] [Abstract][Full Text] [Related]
23. The polymorphisms in the MGMT gene and the risk of cancer: a meta-analysis.
Du L; Wang H; Xiong T; Ma Y; Yang J; Huang J; Zeng D; Wang X; Huang H; Huang J
Tumour Biol; 2013 Oct; 34(5):3227-37. PubMed ID: 23760981
[TBL] [Abstract][Full Text] [Related]
24. A Meta-analysis Assessing the Association Between COL11A1 and GDF5 Genetic Variants and Intervertebral Disc Degeneration Susceptibility.
Wu F; Huang X; Zhang Z; Shao Z
Spine (Phila Pa 1976); 2020 Jun; 45(11):E616-E623. PubMed ID: 31923126
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Association Between
Lv Y; Jia C; Jiang A; Zhang H; Wang Y; Liu F; Yang L; Sun Y; Lv R; Song X
Anticancer Res; 2017 Aug; 37(8):4399-4403. PubMed ID: 28739733
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of 5-hydroxytryptamine type 2A receptor polymorphisms and migraine susceptibility.
Peng JM; Yu YJ; Su LD; Luo X
Int J Neurosci; 2014 Dec; 124(12):882-9. PubMed ID: 25019276
[TBL] [Abstract][Full Text] [Related]
27. Amino acid substitution polymorphisms of the DNA repair gene MGMT and the susceptibility to cervical carcinoma.
Huang J; Ye F; Chen H; Lu W; Xie X
Carcinogenesis; 2007 Jun; 28(6):1314-22. PubMed ID: 17234722
[TBL] [Abstract][Full Text] [Related]
28. MGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case.
Altinoz MA; Elmaci I; Bolukbasi FH; Ekmekci CG; Yenmis G; Sari R; Sav A
J Chemother; 2017 Aug; 29(4):238-244. PubMed ID: 28436299
[TBL] [Abstract][Full Text] [Related]
29. Influence of MTHFR Genetic Background on p16 and MGMT Methylation in Oral Squamous Cell Cancer.
Ferlazzo N; Currò M; Zinellu A; Caccamo D; Isola G; Ventura V; Carru C; Matarese G; Ientile R
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353639
[TBL] [Abstract][Full Text] [Related]
30. Association between six genetic polymorphisms and colorectal cancer: a meta-analysis.
Chen C; Wang L; Liao Q; Xu L; Huang Y; Zhang C; Ye H; Xu X; Ye M; Duan S
Genet Test Mol Biomarkers; 2014 Mar; 18(3):187-95. PubMed ID: 24552298
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the associations between three VEGF polymorphisms and risk of prostate cancer.
Chen GQ; Luo JB; Wang GZ; Ding JE
Tumour Biol; 2014 Mar; 35(3):1875-9. PubMed ID: 24353087
[TBL] [Abstract][Full Text] [Related]
32. Effects of MTHFR C677T and A1298C Polymorphisms on Migraine Susceptibility: A Meta-Analysis of 26 Studies.
Liu L; Yu Y; He J; Guo L; Li H; Teng J
Headache; 2019 Jun; 59(6):891-905. PubMed ID: 31045246
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of the association between a polymorphism in microRNA-196a2 and susceptibility to colorectal cancer.
Shi KQ; Lin Z; Li DW; Fang YX; Gao J; Deng ZJ; Chen L; Li GL; Wu JM; Tang KF
Onkologie; 2013; 36(10):560-5. PubMed ID: 24107909
[TBL] [Abstract][Full Text] [Related]
34. Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis.
Abedinzadeh M; Moghimi M; Dastgheib SA; Maleki H; Salehi E; Zare M; Jarahzadeh HM; Neamatzadeh H
Klin Onkol; 2020; 33(2):92-100. PubMed ID: 32303129
[TBL] [Abstract][Full Text] [Related]
35. Association between IL-1A (-889C/T) polymorphism and susceptibility of chronic periodontitis: A meta-analysis.
Feng X; Liu J
Gene; 2020 Mar; 729():144227. PubMed ID: 31759990
[TBL] [Abstract][Full Text] [Related]
36. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis.
Wang B; Zhu JM; Fan YG; Feng CC; Chen GM; Chen H; Pan HF; Ye DQ
Gene; 2013 Sep; 527(1):95-101. PubMed ID: 23747396
[TBL] [Abstract][Full Text] [Related]
37. A Meta-Analysis of miR-499 rs3746444 Polymorphism for Cancer Risk of Different Systems: Evidence From 65 Case-Control Studies.
Yang X; Li X; Zhou B
Front Physiol; 2018; 9():737. PubMed ID: 29946268
[TBL] [Abstract][Full Text] [Related]
38. FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.
Xu L; Zhou X; Jiang F; Qiu MT; Zhang Z; Yin R; Xu L
PLoS One; 2013; 8(9):e74543. PubMed ID: 24086353
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.
Binabaj MM; Bahrami A; ShahidSales S; Joodi M; Joudi Mashhad M; Hassanian SM; Anvari K; Avan A
J Cell Physiol; 2018 Jan; 233(1):378-386. PubMed ID: 28266716
[TBL] [Abstract][Full Text] [Related]
40. Gene promoter methylation and cancer: An umbrella review.
Bouras E; Karakioulaki M; Bougioukas KI; Aivaliotis M; Tzimagiorgis G; Chourdakis M
Gene; 2019 Aug; 710():333-340. PubMed ID: 31202904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
